Nu Skin Enterprises, Inc. (NUS)
- Previous Close
12.70 - Open
12.58 - Bid --
- Ask --
- Day's Range
12.62 - 13.10 - 52 Week Range
11.84 - 41.50 - Volume
516,535 - Avg. Volume
813,230 - Market Cap (intraday)
646.134M - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
76.53 - EPS (TTM)
0.17 - Earnings Date May 8, 2024
- Forward Dividend & Yield 0.24 (1.89%)
- Ex-Dividend Date Feb 23, 2024
- 1y Target Est
15.50
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
www.nuskin.com3,700
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NUS
Performance Overview: NUS
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUS
Valuation Measures
Market Cap
630.74M
Enterprise Value
970.25M
Trailing P/E
74.71
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.32
Price/Book (mrq)
0.77
Enterprise Value/Revenue
0.49
Enterprise Value/EBITDA
6.98
Financial Highlights
Profitability and Income Statement
Profit Margin
0.44%
Return on Assets (ttm)
4.61%
Return on Equity (ttm)
1.00%
Revenue (ttm)
1.97B
Net Income Avi to Common (ttm)
8.6M
Diluted EPS (ttm)
0.17
Balance Sheet and Cash Flow
Total Cash (mrq)
279.07M
Total Debt/Equity (mrq)
74.28%
Levered Free Cash Flow (ttm)
114.07M
Research Analysis: NUS
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: NUS
NUS: What does Argus have to say about NUS?
NU SKIN ENTERPRISES INC - A has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Low.
RatingBearishPrice TargetNUS: Lowering target price to $10.00
NU SKIN ENTERPRISES INC - A has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice TargetNUS: Raising target price to $11.00
NU SKIN ENTERPRISES INC - A has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice TargetNUS: What does Argus have to say about NUS?
NU SKIN ENTERPRISES INC - A has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice Target